These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [Inhaler therapy for adults with obstructive lung diseases: powder or aerosol?]. Dekhuijzen PN Ned Tijdschr Geneeskd; 1998 Jun; 142(24):1369-74. PubMed ID: 9752023 [TBL] [Abstract][Full Text] [Related]
26. The role of the MDI and DPI in pediatric patients: "Children are not just miniature adults". Ahrens RC Respir Care; 2005 Oct; 50(10):1323-8; discussion 1328-30. PubMed ID: 16185368 [TBL] [Abstract][Full Text] [Related]
27. Aerosol therapy: the special needs of young children. Janssens HM; Tiddens HA Paediatr Respir Rev; 2006; 7 Suppl 1():S83-5. PubMed ID: 16798606 [TBL] [Abstract][Full Text] [Related]
28. Aerosol delivery through an artificial airway. MacIntyre NR Respir Care; 2002 Nov; 47(11):1279-88; discussion 1285-9. PubMed ID: 12425743 [TBL] [Abstract][Full Text] [Related]
29. Aerosol delivery devices in the treatment of asthma. Hess DR Respir Care; 2008 Jun; 53(6):699-723; discussion 723-5. PubMed ID: 18501026 [TBL] [Abstract][Full Text] [Related]
31. Aerosol therapy. Hess D Respir Care Clin N Am; 1995 Dec; 1(2):235-63. PubMed ID: 9390861 [TBL] [Abstract][Full Text] [Related]
32. Emerging aerosol drug delivery strategies: from bench to clinic. Rubin BK; Williams RW Adv Drug Deliv Rev; 2014 Aug; 75():141-8. PubMed ID: 24993613 [TBL] [Abstract][Full Text] [Related]
33. Survey of aerosol delivery techniques to spontaneously breathing tracheostomized children. Willis LD; Berlinski A Respir Care; 2012 Aug; 57(8):1234-41. PubMed ID: 22348743 [TBL] [Abstract][Full Text] [Related]
34. Targeted drug-aerosol delivery in the human respiratory system. Kleinstreuer C; Zhang Z; Donohue JF Annu Rev Biomed Eng; 2008; 10():195-220. PubMed ID: 18412536 [TBL] [Abstract][Full Text] [Related]
35. [Update on inhalation therapy in asthma and obstructive bronchopulmonary diseases]. Boulet LP; d'Amours P; Bérubé D; Rouleau M; Parent JG; Pelletier C; Touchette C Union Med Can; 1994 Jan; 123(1):23-31. PubMed ID: 8109063 [TBL] [Abstract][Full Text] [Related]
36. Can in vitro particle size measurements be used to predict pulmonary deposition of aerosol from inhalers? Thiel CG J Aerosol Med; 1998; 11 Suppl 1():S43-52. PubMed ID: 10180732 [No Abstract] [Full Text] [Related]
38. Influence of propellant composition on drug delivery from a pressurized metered-dose inhaler. Williams RO; Repka M; Liu J Drug Dev Ind Pharm; 1998 Aug; 24(8):763-70. PubMed ID: 9876524 [TBL] [Abstract][Full Text] [Related]
39. Cascade impactors for the size characterization of aerosols from medical inhalers: their uses and limitations. Mitchell JP; Nagel MW J Aerosol Med; 2003; 16(4):341-77. PubMed ID: 14977427 [TBL] [Abstract][Full Text] [Related]
40. Inhalation therapy of the future--how will it change the way we treat asthma? Lötvall J J Aerosol Med; 2001; 14 Suppl 1():S45-50. PubMed ID: 11424893 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]